Bristol Myers Squibb and Celgene Issue Notices of Redemption and Partial Redemption of Certain of Their Senior Notes at "Make Whole" Prices
Bristol-Myers Squibb Company issued a notice of redemption to The Bank of New York Mellon ), as trustee, to redeem all of Bristol Myers Squibb’s 4.000% Notes due 2023 originally issued on November 22, 2019, that remain outstanding after the early settlement of the previously announced tender offers and $42,250,000 principal amount of $932,101,000 principal amount of Bristol Myers Squibb’s outstanding 3.250% … Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol Myers Squibb”) issued a notice of redemption to The Bank of New York Mellon (successor to The Chase Manhattan Bank (National...
Source: investingnews.com